GentleGen
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $14M
Investors
- 6
About GentleGen
, trading as GentleGen, operates as a biotechnology company, specializing in intelligent oligonucleotide synthesis CRDMO services. The company has accumulated dozens of patent applications. In March 2023, GentleGen acquired ISO 9001:2015 Quality Management System Certification and ISO 13485:2016 Quality Management System Certification for Medical Machinery. The company creates automated and intelligent biotechnology applications, combining advanced automation technology to create an intelligent one-stop gene service technology platform for gene synthesis, oligonucleotide synthesis, Sanger sequencing, high-throughput sequencing, gene editing and protein expression, accelerating the progress of life sciences R&D, and upgrading the synthetic biology industry. Meanwhile, GentleGen has established a comprehensive biopharmaceutical safety evaluation system for nucleic acid drugs, cellular and gene therapeutic drugs, gene editing drugs and protein drugs, from early R&D to clinical stage, to ensure the safety of biopharmaceuticals. The company generates revenue by doing R&D, and providing automated gene technology applications and other related products and services.
Who invested in GentleGen
6 investors across 2 rounds
See all investors in GentleGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GentleGen
Who invested in GentleGen?
GentleGen has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GentleGen raised?
GentleGen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GentleGen last raise money?
GentleGen's most recent round on record is a Series A, in Dec 2025.
What does GentleGen do?
, trading as GentleGen, operates as a biotechnology company, specializing in intelligent oligonucleotide synthesis CRDMO services.
Where is GentleGen headquartered?
GentleGen is headquartered in Suzhou, China.
Which VCs invest in companies like GentleGen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GentleGen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GentleGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.